U.S. Markets open in 2 hrs 32 mins

The Panamax (ETR:ICP) Share Price Is Down 88% So Some Shareholders Are Rather Upset

Simply Wall St

Every investor on earth makes bad calls sometimes. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of Panamax AG (ETR:ICP) investors who have held the stock for three years as it declined a whopping 88%. That would be a disturbing experience. And more recent buyers are having a tough time too, with a drop of 74% in the last year. Shareholders have had an even rougher run lately, with the share price down 42% in the last 90 days. We note that the company has reported results fairly recently; and the market is hardly delighted. You can check out the latest numbers in our company report.

We really feel for shareholders in this scenario. It's a good reminder of the importance of diversification, and it's worth keeping in mind there's more to life than money, anyway.

View our latest analysis for Panamax

Panamax recorded just €17,860 in revenue over the last twelve months, which isn't really enough for us to consider it to have a proven product. We can't help wondering why it's publicly listed so early in its journey. Are venture capitalists not interested? As a result, we think it's unlikely shareholders are paying much attention to current revenue, but rather speculating on growth in the years to come. It seems likely some shareholders believe that Panamax will significantly advance the business plan before too long.

Companies that lack both meaningful revenue and profits are usually considered high risk. You should be aware that there is always a chance that this sort of company will need to issue more shares to raise money to continue pursuing its business plan. While some such companies do very well over the long term, others become hyped up by promoters before eventually falling back down to earth, and going bankrupt (or being recapitalized). It certainly is a dangerous place to invest, as Panamax investors might realise.

Panamax had liabilities exceeding cash by €259k when it last reported in December 2019, according to our data. That puts it in the highest risk category, according to our analysis. But with the share price diving 50% per year, over 3 years , it's probably fair to say that some shareholders no longer believe the company will succeed. The image below shows how Panamax's balance sheet has changed over time; if you want to see the precise values, simply click on the image.

XTRA:ICP Historical Debt May 9th 2020

Of course, the truth is that it is hard to value companies without much revenue or profit. Given that situation, would you be concerned if it turned out insiders were relentlessly selling stock? It would bother me, that's for sure. It costs nothing but a moment of your time to see if we are picking up on any insider selling.

A Different Perspective

The last twelve months weren't great for Panamax shares, which performed worse than the market, costing holders 74%. Meanwhile, the broader market slid about 6.5%, likely weighing on the stock. The three-year loss of 50% per year isn't as bad as the last twelve months, suggesting that the company has not been able to convince the market it has solved its problems. Although Baron Rothschild famously said to "buy when there's blood in the streets, even if the blood is your own", he also focusses on high quality stocks with solid prospects. It's always interesting to track share price performance over the longer term. But to understand Panamax better, we need to consider many other factors. Take risks, for example - Panamax has 4 warning signs (and 2 which are significant) we think you should know about.

But note: Panamax may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on DE exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.